
Benjamin Burnett
Stock Analyst at Wells Fargo
(0.15)
# 4,786
Out of 5,162 analysts
464
Total ratings
35.5%
Success rate
-6.7%
Average return
Main Sectors:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Upgraded: Buy | $343 → $509 | $310.90 | +63.72% | 10 | Nov 17, 2026 | |
| ALEC Alector | Initiated Coverage: Buy | $7 | $2.30 | +204.35% | 1 | Nov 13, 2026 | |
| DNLI Denali Therapeutics | Initiated Coverage: Buy | $35 | $18.20 | +92.31% | 1 | Nov 13, 2026 | |
| KRSA Korsana Biosciences | Initiated Coverage: Buy | $44 | $35.45 | +24.12% | 1 | Nov 13, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $72 | $29.48 | +144.23% | 4 | Nov 11, 2026 | |
| LQDA Liquidia | Reiterated: Hold | $33 → $40 | $56.63 | -29.37% | 13 | Nov 11, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $64 | $37.56 | +70.39% | 16 | Nov 11, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $20 → $25 | $28.11 | -11.06% | 4 | Nov 6, 2026 | |
| MNKD MannKind | Reiterated: Buy | $13 | $3.95 | +229.11% | 11 | Nov 5, 2026 | |
| RAPP Rapport Therapeutics | Rated: Buy | $50 → $47 | $23.59 | +99.24% | 6 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $700 → $703 | $559.10 | +25.74% | 14 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $10 | $8.65 | +15.61% | 4 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $68 | $46.18 | +47.25% | 13 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $256 | $135.68 | +88.68% | 12 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $19 | $17.22 | +10.34% | 13 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $112 | $58.33 | +92.03% | 11 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.72 | +414.71% | 11 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $169 | $144.46 | +16.99% | 10 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $21.04 | +342.02% | 5 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.39 | +58.03% | 6 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $18.56 | +137.07% | 2 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $9 | $5.21 | +72.74% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $64 | $159.43 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $13 | $1.01 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.16 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $4 | $0.6669 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.31 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $6.34 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $1.01 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $92 | $76.11 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $10.75 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $49 | $38.93 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $64 | $26.17 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.0002 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $6.91 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.9 → $3.6 | $0.1081 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.7 → $3 | $32.54 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $22.93 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.00001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $20.94 | n/a | 2 | Feb 28, 2022 |
Praxis Precision Medicines
Nov 17, 2026
Upgraded: Buy
Price Target: $343 → $509
Current: $310.90
Upside: +63.72%
Alector
Nov 13, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $2.30
Upside: +204.35%
Denali Therapeutics
Nov 13, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $18.20
Upside: +92.31%
Korsana Biosciences
Nov 13, 2026
Initiated Coverage: Buy
Price Target: $44
Current: $35.45
Upside: +24.12%
Definium Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $72
Current: $29.48
Upside: +144.23%
Liquidia
Nov 11, 2026
Reiterated: Hold
Price Target: $33 → $40
Current: $56.63
Upside: -29.37%
Xenon Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $64
Current: $37.56
Upside: +70.39%
Amphastar Pharmaceuticals
Nov 6, 2026
Reiterated: Hold
Price Target: $20 → $25
Current: $28.11
Upside: -11.06%
MannKind
Nov 5, 2026
Reiterated: Buy
Price Target: $13
Current: $3.95
Upside: +229.11%
Rapport Therapeutics
Nov 5, 2026
Rated: Buy
Price Target: $50 → $47
Current: $23.59
Upside: +99.24%
Nov 5, 2026
Rated: Buy
Price Target: $700 → $703
Current: $559.10
Upside: +25.74%
Nov 4, 2026
Reiterated: Hold
Price Target: $13 → $10
Current: $8.65
Upside: +15.61%
Nov 3, 2026
Reiterated: Buy
Price Target: $65 → $68
Current: $46.18
Upside: +47.25%
Nov 3, 2026
Rated: Buy
Price Target: $256
Current: $135.68
Upside: +88.68%
Nov 3, 2026
Reiterated: Hold
Price Target: $18 → $19
Current: $17.22
Upside: +10.34%
Oct 30, 2026
Reiterated: Buy
Price Target: $109 → $112
Current: $58.33
Upside: +92.03%
Oct 28, 2026
Reiterated: Buy
Price Target: $14
Current: $2.72
Upside: +414.71%
Oct 13, 2026
Rated: Buy
Price Target: $169
Current: $144.46
Upside: +16.99%
Sep 29, 2026
Rated: Buy
Price Target: $93
Current: $21.04
Upside: +342.02%
Sep 2, 2026
Reiterated: Buy
Price Target: $18
Current: $11.39
Upside: +58.03%
Aug 31, 2026
Reiterated: Buy
Price Target: $44
Current: $18.56
Upside: +137.07%
Aug 11, 2026
Rated: Buy
Price Target: $9
Current: $5.21
Upside: +72.74%
Apr 1, 2025
Reiterated: Buy
Price Target: $78 → $64
Current: $159.43
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $26 → $13
Current: $1.01
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $4.16
Upside: n/a
Mar 17, 2025
Reiterated: Hold
Price Target: $4.5 → $4
Current: $0.6669
Upside: n/a
Mar 17, 2025
Reiterated: Buy
Price Target: $18
Current: $7.31
Upside: n/a
Mar 11, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $6.34
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $1.01
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $94 → $92
Current: $76.11
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $80
Current: $10.75
Upside: n/a
Feb 13, 2025
Reiterated: Hold
Price Target: $53 → $49
Current: $38.93
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $66 → $64
Current: $26.17
Upside: n/a
Apr 19, 2024
Reiterated: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 16, 2023
Reiterated: Buy
Price Target: $42
Current: $6.91
Upside: n/a
Aug 10, 2023
Reiterated: Hold
Price Target: $3.9 → $3.6
Current: $0.1081
Upside: n/a
Mar 2, 2023
Reiterated: Hold
Price Target: $4.7 → $3
Current: $32.54
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $22.93
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.00001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $20.94
Upside: n/a